EMD.AX · EMYRIA LIMITED
Australia · RS rating 19 · As of 2026-10-14
| Price | 0.04 AUD |
|---|---|
| 1-day change | -2.4% |
| RS rating (overall / 1M / 3M / 12M) | 19 / 10 / 23 / 35 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 13 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +46.0% |
| Market cap (USD) | $23.6M |